---
title: "Genetic Technologies Warrants Lapse on Expiry, Trimming Potential Dilution"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275095960.md"
description: "Genetic Technologies Limited announced that 1,959,750 GTGAF warrants have lapsed as of February 6, 2026, reducing potential dilution from outstanding convertible instruments. This update simplifies the company's capital structure, which may interest shareholders. The current analyst rating for GTG stock is a Hold with a price target of A$0.04, and the market cap stands at A$5.67M."
datetime: "2026-02-06T08:28:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275095960.md)
  - [en](https://longbridge.com/en/news/275095960.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275095960.md)
generator: "portal-rs"
---

# Genetic Technologies Warrants Lapse on Expiry, Trimming Potential Dilution

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Genetic Technologies ( (AU:GTG) ) just unveiled an update.

Genetic Technologies Limited has notified the market that 1,959,750 GTGAF warrants have lapsed following their expiry without being exercised or converted as of 6 February 2026. The cessation of these securities marginally reduces the company’s potential dilution from outstanding convertible instruments and slightly simplifies its capital structure, a routine housekeeping step that may be of interest to existing shareholders monitoring issued and potential share capital.

The most recent analyst rating on (AU:GTG) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Genetic Technologies stock, see the AU:GTG Stock Forecast page.

**More about Genetic Technologies**

Genetic Technologies Limited, listed on the ASX under the code GTG, operates in the biotechnology sector, focusing on genetic testing and related technologies, and is part of Australia’s broader life sciences and diagnostics market.

**Technical Sentiment Signal:** Sell

**Current Market Cap:** A$5.67M

See more insights into GTG stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [GTG.AU](https://longbridge.com/en/quote/GTG.AU.md)

## Related News & Research

- [UBS Remains a Buy on Westgold Resources (WGXRF)](https://longbridge.com/en/news/298147187.md)
- [Santos To Increase Interest In Papua LNG For $189 Mln](https://longbridge.com/en/news/298183350.md)
- [PRECIOUS-Gold little changed as markets await key US inflation data](https://longbridge.com/en/news/298146831.md)
- [Spain's Ignis targets October IPO to raise up to €600 million, report says](https://longbridge.com/en/news/298175633.md)
- [Baidu’s Xiaodu schedules AI hardware launch for Sept. 8](https://longbridge.com/en/news/298171383.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**